act glutathione extra strength results rna Results Rna

10.2165/00003495-200363010-00005 172 MacDonald-WicksL

Most patients experience no downtime or significant side effects, though minor bruising or discomfort at the injection site may occur

Similarly, an intravenous GSH trial found no significant differences in motor or activities of daily living (ADL) scores between the GSH and placebo groups at week 4 or during follow-up, suggesting only minimal symptomatic benefits (Hauser et al., 2009)

The findings from this study not only advance our knowledge of SVV pathogenesis but also contribute to the broader understanding of virus-host interactions, particularly how viruses exploit cellular death pathways to their advantage